Evonik’ realigns’ portfolio to focus on nutrition and sustainability

By Will Chu

- Last updated on GMT


Related tags: Evonik, Nutrition, Sustainability

Evonik has revealed details of a €3bn investment to the business that looks to ‘realign’ its portfolio management, innovation and corporate culture by 2030.

In a statement, the phytochemical firm outlined plans that involve aligning its portfolio to its three growth divisions: Nutrition & Care, Specialty Additives, and Smart Materials.

Evonik revealed it will also exit its Performance Materials - Superabsorbents, Functional Solutions and Performance Intermediate businesses with plans now in motion to find new owners or partners next year.

“The businesses we are withdrawing from on strategic grounds are being optimally set up to give them a responsible route to a good future,”​ explains Christian Kullmann, Chairman of Evonik's executive board.

Sustainability benefits

Sale proceeds from the Performance Materials businesses along with future operating cash flow will be channelled towards the firm’s switch to more environmentally friendly operation.

By 2030, Evonik aims to invest more than €3bn in Next Generation Solutions - products with superior sustainability benefits.

That is around 80% of annual growth investments. In the same period, a further €700m will be invested in Next Generation Technologies that “optimise production processes and infrastructure to avoid CO2 emissions.”

“We are greatly increasing our handprint and reducing our footprint at the same time,”​ says Thomas Wessel, the executive board member responsible for sustainability.

“Translated into KPIs: We will substantially increase the sales share of our Next Generation Solutions from 37% at present to over 50% by 2030.”

“That includes, for example, drug delivery technologies for controlled release of pharmaceutical active ingredients, as well as natural-based active ingredients for cosmetics.”

Leading Beyond Chemistry

As part of an ethos that commits to ‘Leading Beyond Chemistry,’ Evonik are to launch a new Sustainability Tech Fund investing €150m to help develop innovative technologies and business models.

“The focus is on new technologies that will reduce emissions as well as on innovations that have a high technological fit with the Next Generation Solutions,”​ the firm says.

Evonik’s Research, Development & Innovation unit is also undergoing a sustainability makeover with the arm on track to generate additional sales of more than €1bn with its innovation growth fields by 2025, according to Harald Schwager, executive board member responsible for innovation.

“Our innovative capability is a key factor in leveraging green and profitable growth,”​ he adds.

Related news

Related products

show more

Happier with indication-specific probiotics

Happier with indication-specific probiotics

Winclove Probiotics | 07-Jun-2022 | Product Brochure

From the very founding of Winclove Probiotics, our aim to help people, society, and the world has been an essential part of our business DNA.

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

Botanicals you can rely on, from ADM

Botanicals you can rely on, from ADM

ADM | 02-Jun-2022 | Product Brochure

Today more than ever, consumers are striving to support their overall well-being in a convenient way, with foods, beverages and dietary supplements that...

Set your brand apart with Collavant n2

Set your brand apart with Collavant n2

BIOIBERICA, S.A.U. | 17-May-2022 | Technical / White Paper

Native type II. Hydrolysed. Undenatured. There’s a variety of collagen products available on the market – but how can formulators identify the solution...

Related suppliers

Follow us


View more